CIK: 0001807489 · Show all filings
Period: Q2 2023 (← Previous) (Next →)
Filing Date: Aug 11, 2023
Total Value ($000): $75,678 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WVE | WAVE LIFE SCIENCES LTD | 7,050,000 | $25,662 | 33.9% | $3.31 | +22.1% | SHS | Y95308105 |
| RCKT | ROCKET PHARMACEUTICALS INC | 630,380 | $12,526 | 16.6% | $23.75 | -14.9% | COM | 77313F106 |
| IVVD | INVIVYD INC | 9,248,250 | $9,711 | 12.8% | $17.64 | -92.8% | COM | 00534A102 |
| — | SPRINGWORKS THERAPEUTICS INC | 197,700 | $5,184 | 6.8% | $25.89 | — | COM | 85205L107 |
| — | CURIS INC | 6,000,000 | $4,980 | 6.6% | $2.96 | — | COM NEW | 231269200 |
| STOK | STOKE THERAPEUTICS INC | 346,190 | $3,680 | 4.9% | $22.47 | -52.7% | COM | 86150R107 |
| TGTX | TG THERAPEUTICS INC | 142,500 | $3,540 | 4.7% | $16.30 | +58.4% | COM | 88322Q108 |
| PRQR | PROQR THRAPEUTICS N V | 1,910,600 | $3,095 | 4.1% | $2.38 | -17.9% | SHS EURO | N71542109 |
| BBIO | BRIDGEBIO PHARMA INC | 166,200 | $2,859 | 3.8% | $39.38 | -61.8% | COM | 10806X102 |
| ARWR | ARROWHEAD PHARMACEUTICALS IN | 67,400 | $2,403 | 3.2% | $33.13 | +4.1% | COM | 04280A100 |
| SLN | SILENCE THERAPEUTICS PLC | 363,800 | $2,001 | 2.6% | $9.41 | — | ADS | 82686Q101 |
| — | NEXIMMUNE INC | 133,442 | $38 | 0.0% | $4.61 | — | COM | 65344D109 |